Display Single Record

FOI Request

Disclosure ID
FOI/00964
Request Date
May 12, 2016
Subject
Oncology Drugs
Description

Within your trust how many unique patients with Advanced Prostate Cancer (C61X) have been treated in the past 12 months?

How many patients with Advanced Prostate Cancer have received?

Abiraterone (Zytiga)  
Cabazitaxel (Jevtana)  
Docetaxel (Taxotere)  
Enzalutamide (Xtandi)  
Radium-223 (Xofigo)  
Bicalutamide (Casodex)  

 

Within your trust how many unique patients with Hepatocellular Carcinoma (C220) have been treated in the past 12 months?

How many patients with with Hepatocellular Carcinoma have received?

Bevacizumab (Avastin)  
Everolimus (Afinitor)  
Lapatinib (Tyverb)  
Sorafenib (Nexavar)  
Sunitinib (Sutent)  

 

Within your trust how many unique patients with Gastrointestinal Stromal Tumours (C269) have been treated in the past 12 months?

How many patients with with Gastrointestinal Stromal Tumours have received?

Dasatinib (Sprycel)  
Imatininb (Glivec)  
Nilotinib (Tasigna)  
Pazopanib (Votrient)  
Regorafenib (Stivarga)  
Sorafenib (Nexavar)  
Sunitinib (Sutent)  
Response

Unfortunately the Pharmacy IT system doesn’t store the clinical indication, we have supplied the quantities and attached a spreadsheet which breaks it down by month.

 

Chemical Total
Abiraterone Acetate 44,630
Bevacizumab 266
Bicalutamide 10,437
Cabazitaxel 6
Dasatinib 3,191
Docetaxel 512
Enzalutamide 60,228
Everolimus 1,350
Nilotinib 7,244
Pazopanib 4,505
Sorafenib 1,596
Sunitinib 2,579
Attachment 1
data_sheet_foi_00964.pdf
Attachment 2
Attachment 3
Attachment 4
Attachment 5
Attachment 6
Attachment 7
Attachment 8
Attachment 9